2Scandinavian Simvastatin Survival Study Group (1994).Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S)[J].Lancet,1994,344(8934):1383-1389.
3Orn S,Cleland JG,Romo M,et al.Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction[J].Am J Med,2005,118(7):752-758.
4Braunwald E,Bristow MR.Congestive heart failure:fifty years of progress[J].Circulation,2000,102 (20):IV-14-23.
5Laufs U,la Fata V,Plutzky J,et al.Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors[J].Circulation,1998,97(12):1129-1135.
6Strey CH,Young JM,Lainchbury JH,et al.Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure[J].Heart,2006,92(11):1603-1609.
7Ferro D,Parrotto S,Basili S,et al.Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia[J].J Am Coll Cardiol,2000,36(2):427-431.
8Sola S,Mir MQS,Lerakis S,et al.Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure[J].J Am Coll Cardiol,2006,47(2):332-337.
9Hayashidani S,Tsutsui H,Shiomi T,et al.Fluvastatin,a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,attenuates left ventricular remodeling and failure after experimental myocardial infarction[J].Circulation,2002,105(7):868-873.
10Dechend R,Fiebeler A,Park J,et al.Amelioration of angiotensin Ⅱ-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor[J].Circulation,2001,104(5):576-581.
